Hematology NewsFrontline myeloma treatments: ASCT vs. CAR TOctober 25, 2023Multiple MyelomaTransplantCellular Therapy
Hematology NewsFDA approves motixafortide for stem cell mobilization in myelomaSeptember 11, 2023Multiple MyelomaTransplantCellular Therapy
Hematology NewsAntibody shows promise in preventing GVHDAugust 8, 2023TransplantMixed TopicsMultiple MyelomaNon-Hodgkin LymphomaHodgkin LymphomaB Cell LymphomaCLL
Hematology NewsESMO helps hematologists assess new cancer drugsJune 28, 2023Mixed TopicsCellular TherapyCMLCLLAggressive LymphomasALLAML
Oncology PracticeMultiprong strategy makes clinical trials less WhiteJune 23, 2023Diversity in MedicinePatient & Survivor CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
Oncology PracticeCBSM phone app eases anxiety, depression in cancer patientsJune 23, 2023Patient & Survivor CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
Hematology NewsCAR T-cell benefit in lenalidomide-refractory myelomaJune 23, 2023Multiple MyelomaImmunotherapyImmuno-oncology
Oncology PracticeHuge underuse of germline testing for cancer patientsJune 22, 2023Patient & Survivor CarePreventive CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
Oncology PracticeDEI training gives oncology fellows more confidenceJune 22, 2023Diversity in MedicinePractice ManagementRenal Cell CarcinomaSarcoma & GISTCNS/Brain CancerDLBCLFollicular Lymphoma
Oncology PracticeDrugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get medsJune 22, 2023Patient & Survivor CarePractice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
